Prostate Cancer

Latest News

Irreversible electroporation with NanoKnife found safe, effective for prostate tissue ablation
Irreversible electroporation with NanoKnife found safe, effective for prostate tissue ablation

July 22nd 2025

The PRESERVE trial met its primary end point by demonstrating a negative in-field biopsy rate of 71% at 12 months.

Prostate cancer, 3D illustration showing presence of tumor inside prostate gland which compresses urethra | Image Credit: © Dr_Microbe - stock.adobe.com
Darolutamide plus ADT approved in EU for mHSPC

July 21st 2025

Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
Phase 3 TALAPRO-2 data of talazoparib plus enzalutamide published in The Lancet

July 18th 2025

Urology in focus: Key moments from 2025
Urology in focus: Key moments from 2025

July 18th 2025

CMS issues reimbursement code for PSMA-PET imaging agent Gozellix
CMS issues reimbursement code for PSMA-PET imaging agent Gozellix

July 15th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.